Vitamin E supplementation and oxidative status of peripheral blood mononuclear cells and lymphocyte subsets in hemodialysis patients.
Increased oxidative damage to cell membrane constituents causes profound changes in the membrane cytoarchitecture and modifications of the membrane physiological properties, e.g., the ability to respond to hormonal stimuli. In uremic patients receiving intermittent hemodialysis, a metabolic block of the phosphate pentose shunt has been described. This leads to insufficient detoxication of the hydroxyl radicals formed within the cells and therefore to increased oxidative damage to the polyunsaturated fatty acid constituents of the cell membranes. Vitamin E is known to reduce this oxidative damage and its harmful effects. We studied vitamin E (alpha-tocopherol acetate) administration in 10 chronically uremic patients receiving intermittent hemodialysis for positive effects on cell membrane-receptor response. The patients were studied before and after treatment for the extent of oxidative damage in peripheral mononuclear cells and for response to monoclonal antibodies to specific markers of T-lymphocyte subsets. After vitamin E treatment, oxidative damage decreased, and the membranes of peripheral mononuclear cells contained greater amounts of some unsaturated fatty acids. This is in agreement with a modification of the membrane phenotype markers of T-lymphocyte subsets and seems to confirm in vivo that changes in membrane structure first induced by increased oxidative damage due to the blockage of the phosphate pentose shunt can be reduced by the antioxidant action of vitamin E, which significantly influences the expression of membrane determinants.
Lubrano
R
R
Clinica Pediatrica Universita La Sapienza, Rome, Italy.
Taccone-Gallucci
M
M
Piazza
A
A
Morosetti
M
M
Meloni
C
C
Citti
G
G
Mannarino
O
O
Castello
M A
MA
Casciani
C U
CU
D000328:Adult; D005227:Fatty Acids / Q000032:analysis*; D005260:Female; D005609:Free Radicals; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000737:chemistry* / Q000187:drug effects; D016131:Lymphocyte Subsets / Q000737:chemistry / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000378:metabolism; D014810:Vitamin E / Q000627:therapeutic use*
D005227:Fatty Acids; D005609:Free Radicals; D014810:Vitamin E